AU2002309842B2 - Treating epidermlyosis bullosa with thymosin beta 4 - Google Patents

Treating epidermlyosis bullosa with thymosin beta 4 Download PDF

Info

Publication number
AU2002309842B2
AU2002309842B2 AU2002309842A AU2002309842A AU2002309842B2 AU 2002309842 B2 AU2002309842 B2 AU 2002309842B2 AU 2002309842 A AU2002309842 A AU 2002309842A AU 2002309842 A AU2002309842 A AU 2002309842A AU 2002309842 B2 AU2002309842 B2 AU 2002309842B2
Authority
AU
Australia
Prior art keywords
composition
polypeptide
epidermolysis bullosa
skin
thymosin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002309842A
Other languages
English (en)
Other versions
AU2002309842A1 (en
Inventor
Jack Finkelstein Jr.
Allan L. Goldstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RegeneRx Biopharmaceuticals Inc
Original Assignee
RegeneRx Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RegeneRx Biopharmaceuticals Inc filed Critical RegeneRx Biopharmaceuticals Inc
Publication of AU2002309842A1 publication Critical patent/AU2002309842A1/en
Application granted granted Critical
Publication of AU2002309842B2 publication Critical patent/AU2002309842B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002309842A 2001-05-17 2002-05-16 Treating epidermlyosis bullosa with thymosin beta 4 Ceased AU2002309842B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29132601P 2001-05-17 2001-05-17
US60/291,326 2001-05-17
PCT/US2002/015394 WO2002091969A1 (en) 2001-05-17 2002-05-16 Treating epidermlyosis bullosa with thymosin beta 4

Publications (2)

Publication Number Publication Date
AU2002309842A1 AU2002309842A1 (en) 2003-05-01
AU2002309842B2 true AU2002309842B2 (en) 2006-02-02

Family

ID=23119854

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002309842A Ceased AU2002309842B2 (en) 2001-05-17 2002-05-16 Treating epidermlyosis bullosa with thymosin beta 4

Country Status (7)

Country Link
EP (1) EP1404268A4 (enExample)
JP (1) JP2004525988A (enExample)
CN (1) CN1241636C (enExample)
AU (1) AU2002309842B2 (enExample)
CA (1) CA2446072A1 (enExample)
MX (1) MXPA03010446A (enExample)
WO (1) WO2002091969A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007521336A (ja) * 2003-12-22 2007-08-02 リジェナークス・バイオファーマシューティカルズ・インコーポレイテッド 反応性化学物質、生物学的物質、もしくは毒素に対する、生物学的もしくは免疫学的応答を、処理もしくは防止する方法
EP2260106A4 (en) * 2008-03-17 2011-04-20 Regenerx Biopharmaceuticals IMPROVED BETATHYMOSINFRAGMENTS
US8632827B2 (en) * 2011-12-13 2014-01-21 Avon Products, Inc Modulation of thymosin beta-4 in skin
WO2014093053A1 (en) * 2012-12-11 2014-06-19 Avon Products, Inc. Modulation of thymosin beta-4 in skin
CN104324279A (zh) * 2014-11-19 2015-02-04 吕玲 一种治疗皮肤发育不良的中药药剂及制备方法
WO2017214910A1 (zh) * 2016-06-15 2017-12-21 石庆学 特异促进Tβ4基因高表达的慢病毒表达载体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087341A (en) * 1998-02-12 2000-07-11 The Board Of Trustees Of The Leland Standford Junior University Introduction of nucleic acid into skin cells by topical application
EP2311485A1 (en) * 1998-07-30 2011-04-20 The Government of the United States of America, as represented by the Secretary of Health and Human Services Thymosin beta 4 promotes wound repair

Also Published As

Publication number Publication date
CN1241636C (zh) 2006-02-15
CA2446072A1 (en) 2002-11-21
CN1511017A (zh) 2004-07-07
JP2004525988A (ja) 2004-08-26
EP1404268A4 (en) 2006-03-01
MXPA03010446A (es) 2004-12-06
WO2002091969A1 (en) 2002-11-21
EP1404268A1 (en) 2004-04-07

Similar Documents

Publication Publication Date Title
AU2003296875B2 (en) Treatment of infections and other disorders
US9056087B2 (en) Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives
AU2002336408A1 (en) Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives
AU2002255736B2 (en) Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (Tbeta4), analogues, isoforms and other derivatives
JP2009046502A (ja) 皮膚状態の改善を促進するための組成物の製造のための、アミノ酸配列ｌｋｋｔｅｔを含む皮膚変性阻害ポリペプチドの使用
AU2002255736A1 (en) Methods of Treating Disorders of the Eye and Surrounding Tissue with Thymosin Beta4 (TBeta4), Analogues, Isoforms and Other Derivatives
AU2002309842B2 (en) Treating epidermlyosis bullosa with thymosin beta 4
US20110020449A1 (en) Methods of treating disorders of the eye and surrounding tissue with thymosin beta 4 (tb4), analogues, isoforms and other derivatives
AU2002309842A1 (en) Treating epidermlyosis bullosa with thymosin beta 4
US20060246057A1 (en) Treatment or prevention of damage due to radiation exposure
US20080096817A1 (en) METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (Tbeta4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
AU2002213513A1 (en) Inhibition or reversal of skin aging by actin-sequestering peptides
US20040170625A1 (en) Methods of treating Epidermolysis Bullosa and associated dermatological indications with thymosin beta 4, analogues, isoforms and other derivatives
US20040067227A1 (en) Inhibition or reversal of skin aging by actin-sequestering peptides
AU2008201749B2 (en) Treatment of Infections and Other Disorders
HK1151729A (en) Treatment of infections and other disorders

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired